You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 April 2014
Affimed Therapeutics AG: Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting
8 October 2012
Affimed Therapeutics AG: Affimed raises EUR 15.5 million in a Series D financing round